This country profile provides an overview of Cabo Verde’s progress in reaching those in need of mass NTD treatment based on 2017 data.

*This includes all countries in Africa that are endemic for at least one of the five NTDs

Download country profiles

Treatment coverage

Elephantiasis
N/A
Blinding trachoma
N/A
Intestinal worms
NR
Bilharzia
N/A
River blindness
N/A

Priorities for progress in Cabo Verde

  • As a priority, Cabo Verde should submit the data on preventive chemotherapy coverage for intestinal worms to WHO.
  • Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.

Elephantiasis

Cabo Verde does not require mass treatment for elephantiasis.

Blinding trachoma

Cabo Verde does not require mass treatment for blinding trachoma.

Intestinal worms

Treatment coverage was 61% in 2016 and not reported in 2017.

Pre-sch and school-aged children needing treatment
0.15m
Pre-school and school-aged children receiving treatment
Not reported

Bilharzia

Cabo Verde does not require mass treatment for bilharzia.

River blindness

Cabo Verde does not require mass treatment for river blindness.

The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Cabo Verde.